KANMONY MATHEW: Open Payments
NPI 1124491618 · RICHMOND, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$279 in 13 payments from 5 companies in 2025. Trend: 2023 $381 · 2024 $525 · 2025 $279
Food & beverage: $279
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 4 | $101 |
| Amgen Inc. | 5 | $89 |
| AstraZeneca Pharmaceuticals LP | 2 | $39 |
| SCPHARMACEUTICALS INC. | 1 | $28 |
| PFIZER INC. | 1 | $23 |
Products named: LEQVIO, REPATHA, FUROSCIX, WAINUA, ELIQUIS, FARXIGA.
Industry payments across TX — which companies pay providers there.
